Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Drospirenone + Ethinyl Estradiol vs Yasmin in Healthy Thai Females
NCT06233058Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Mar 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of drospirenone and ethinyl estradiol in contraception (2 arms), sponsored by Bio-innova. Primary endpoints: Area under the plasma concentration-time curve from time zero to the last measurable concentration at 72 hours and Maximal measured plasma concentration at 72 hours. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
drospirenoneethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06233058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06233058.